Letter to the editor regarding "Association between central sensitization-related symptoms and pressure pain thresholds at local and remote sites in patients with knee osteoarthritis".

Central sensitization (CS) is an increasingly recognized determinant of pain severity and postoperative outcomes in knee osteoarthritis, yet how best to measure it in clinical practice remains unsettled. We comment on a recent cross-sectional study of 121 patients awaiting total knee arthroplasty,which found that higher Central Sensitization Inventory (CSI) scores were independently associated with lower remote, but not local, pressure pain thresholds (PPTs), suggesting that CSI reflects widespread rather than localized pain hypersensitivity. We highlight that CSI and remote PPT are indirect, complementary measures rather than confirmatory proof of a central mechanism, and that pairing them with quantitative sensory testing could increase their clinical utility. We also note limitations affecting generalizability, including the advanced-disease cohort, cross-sectional design, and unmeasured covariates. Prospective, multicentre studies linking these measures to postoperative outcomes could translate this work into individualized perioperative pain management for patients undergoing knee arthroplasty.